US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Neurizon Therapeutics Ltd (PAAOA) 銘柄情報

Neurizon Therapeutics Ltd (PAAOA)

0.11

0.00

( 0.00% )

更新日時： 09:00:00

Neurizon Therapeutics Ltd (PAAOA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.11

( - )

買値

0.11

売値

0.12

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.11

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 584,125

発行済株式数

746,274,115

配当利回り

PER

-2.03

1 株当たり利益 (EPS)

-0.03

歳入

5.98M

純利益

-14.85M

Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.neurizon.com

本社

Melbourne, Australia

設立

2026

Neurizon Therapeutics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker PAAOA. The last closing price for Neurizon Therapeutics was AUD0.11. Over the last year, Neurizon Therapeutics shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Neurizon Therapeutics currently has 746,274,115 shares in issue. The market capitalisation of Neurizon Therapeutics is AUD82.09 million. Neurizon Therapeutics has a price to earnings ratio (PE ratio) of -2.03.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PAAOA - Frequently Asked Questions (FAQ)

What is the current Neurizon Therapeutics Ltd share price?

The current share price of Neurizon Therapeutics Ltd is AUD 0.11

How many Neurizon Therapeutics Ltd shares are in issue?

Neurizon Therapeutics Ltd has 746,274,115 shares in issue

What is the market cap of Neurizon Therapeutics Ltd?

The market capitalisation of Neurizon Therapeutics Ltd is AUD 82.09M

What is the 1 year trading range for Neurizon Therapeutics Ltd share price?

Neurizon Therapeutics Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Neurizon Therapeutics Ltd?

The price to earnings ratio of Neurizon Therapeutics Ltd is -2.03

What is the cash to sales ratio of Neurizon Therapeutics Ltd?

The cash to sales ratio of Neurizon Therapeutics Ltd is 7.49

What is the registered address of Neurizon Therapeutics Ltd?

The registered address for Neurizon Therapeutics Ltd is Suite 2, Melbourne, Victoria, 3000

What is the Neurizon Therapeutics Ltd website address?

The website address for Neurizon Therapeutics Ltd is www.neurizon.com

gfp927z

gfp927z 4分前

>>> Gaven Industries — Company Overview and Stock Information

Gaven Industries Inc. is a privately held U.S. manufacturer specializing in electromagnetic (RF, EMI, EMP, HEMP) shielding solutions, serving defense, industrial, critical infrastructure, and healthcare sectors. It is not p

Forensics888

Forensics888 5分前

What? Just calling out BS when someone repeatedly attacks me. See how easy that is? No knowledge required for that simple truth.

Homebrew

Homebrew 6分前

Says every garbage ticker....but never happens.
...short squeeze coming...

Smartypants2

Smartypants2 7分前

In other words, you don't have an innocent explanation why someone would do that 3 times within 13 seconds.

Zardiw

Zardiw 10分前

$SUNE - #DDAmanda Chart. Where does this go from here?

https://DDAmanda.com/Charts/DDAmandaSUNE.jpg

https://DDAmanda.com

Z

Zardiw

Zardiw 11分前

$SUNE - #DDAmanda Chart. Where does this go from here?

https://DDAmanda.com/Charts/DDAmandaSUNE.jpg

https://DDAmanda.com

Z

Zardiw

Zardiw 12分前

$SUNE - #DDAmanda Chart. Where does this go from here?

https://DDAmanda.com/Charts/DDAmandaSUNE.jpg

https://DDAmanda.com

Z

GenerationPoverty

GenerationPoverty 12分前

I was shocked to see it “gain” after that last PR, but I won’t complain about the price not falling on a Monday!

Dabeav

Dabeav 14分前

Nobody gives 2 shits bout degrees with this stock! Come on man!

US Market News

US Market News 15分前

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded WarrantsJune 8, 2026 10:22 PM
PR Newswire (US) class="legendSpanClass"SOUTH SAN FRANCISCO, Calif., class="legendSpanClass"June 8, 2026 /PRNewswire/ -- IDEAY

biosectinvestor

biosectinvestor 15分前

Awesome find StonkMaster!

NWBO is listed as a collaborator in the newly posted Phase 2 Kalinski Alpha-DC1 ovarian-cancer trial.

The study is small but meaningful: an estimated 28-patient, open-label, non-randomized trial in advanced-stage ovarian, tubal, or peritoneal c

Dabeav

Dabeav 16分前

Nothing to say it’s not

Stumblebum

Stumblebum 19分前

Mine doesn’t include any Novartis involvement…..this EF one I feel is with a “partnership”…..I’ve for the last year or so always saw Novartis as the number one pharmaceutical that would buyout Uncy….whatever makes the sp go up I’m fine with it….got a whole mess of a lot of shares ….let the games beg

Kool Aid Man

Kool Aid Man 23分前

Baloney..."Vakser resigns" from all his tickers..but always returns! He does this every time he runs a ticker into the ground.

(2013) "ProTek Capital $PRPM announces today the resignation of Edward Vakser as chief executive officer of ProTek Capital..."
https://finance.yahoo.

along4zride

along4zride 26分前

Investors turn on each other as path forward narrows. Seasoned board veteran has pointed out the issues for years unfortunately going on deaf ears blinded by (FNMA) greed . While 47 relaxes watching ball game before opening bell daily optimistic investors are sweating bullets to see how much penny s

simplysouthern

simplysouthern 27分前

Why all the sudden volume? Is this being pumped by another site? Somedays there’s nothing then other days, it’s steady. Thoughts?

Koog

I'm an engineer with 35 years of experience in the semiconductor industry
You seem to be new here. That will automatically make anything you post here incorrect.

peafunke

peafunke 29分前

KCCO7913

KCCO7913 29分前

The SAM figure is likely derived mostly from LightCounting's reports. A couple years ago, a LightCounting report separated out PIC sales by material type and "TFLN and other" had its own category. I don't recall exactly off the top of my head, but I think it was estimated to be around $1.5 billion i

gmac8625

gmac8625 30分前

All good, natural questions. It would seemingly be the biggest blunder ever if they don’t do anything we have full capitulation right now and the stars seem to be aligned (or very close to). It is harder to come up with an excuse not to right now….my fear is the admin trying to be so cute to maximi

peafunke

peafunke 31分前

Let’s go. Next two weeks it is. But should see what’s behind door number one end of week 🤞🤞🤞

I leave for a bit and…. ;)

raiderz

raiderz 35分前

HIRU was so blatant with their promotion they earned a warning badge from OTC in fall of 2024.

After that, a set of paid accounts rotated in and out pumping HIRU here, on X, and stocktwts.

Where’s the goldenpump? Gone from here, and x. For someone who likes “cheapies”

DJurg

They sold 10.9M shares last quarter - and 4.1 M SO FAR this quarter - so they are by no means done selling shares

Duke Knockem

Duke Knockem 36分前

CHME is not current yet, but I'm expecting to see the fillings appearing really soon. next step should be the shell badge appearance on the OTC market website. I'm not too sure what is Belisarian strategy there ...they have encc and Zhud current and soon chme and AHFI ....yet they struggle to find a

Neurizon Therapeutics

CI Tech Giants Covered C...

Tower Bridge Funding

Pine Trail Real Estate I...

Republic of Peru

Direxion Daily Technolog...

Espre Technologies (PK)

Atossa Therapeutics

Critical Resources

JP Morgan Income ETF

ETFlab Investment

Exchange Traded

Medical Facilities

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。